These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12003097)

  • 1. Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans.
    De Vito G; Galloway SD; Nimmo MA; Maas P; McMurray JJ
    Clin Physiol Funct Imaging; 2002 Jan; 22(1):32-8. PubMed ID: 12003097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of moxonidine on cardiac autonomic modulation.
    Kaya D; Barutcu I; Esen AM; Celik A; Onrat E
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):929-33. PubMed ID: 20230461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress.
    Wenzel RR; Mitchell A; Siffert W; Bührmann S; Philipp T; Schäfers RF
    Br J Clin Pharmacol; 2004 May; 57(5):545-51. PubMed ID: 15089806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives.
    Wenzel RR; Spieker L; Qui S; Shaw S; Lüscher TF; Noll G
    Hypertension; 1998 Dec; 32(6):1022-7. PubMed ID: 9856967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poincaré plot indices as measures of sympathetic cardiac regulation: Responses to psychological stress and associations with pre-ejection period.
    Rahman S; Habel M; Contrada RJ
    Int J Psychophysiol; 2018 Nov; 133():79-90. PubMed ID: 30107195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine.
    Mobini R; Fu M; Jansson PA; Bergh CH; Scharin Täng M; Waagstein F; Andersson B
    Clin Sci (Lond); 2006 Mar; 110(3):329-36. PubMed ID: 16209659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans.
    Galloway SD; De Vito G; McClure S; Nimmo MA; McMurray JJ
    Clin Sci (Lond); 2000 Sep; 99(3):223-30. PubMed ID: 11787475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
    Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous system representation in time and frequency domain indices of heart rate variability.
    Polanczyk CA; Rohde LE; Moraes RS; Ferlin EL; Leite C; Ribeiro JP
    Eur J Appl Physiol Occup Physiol; 1998 Dec; 79(1):69-73. PubMed ID: 10052663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Moxonidine Investigators.
    Swedberg K; Bergh CH; Dickstein K; McNay J; Steinberg M
    J Am Coll Cardiol; 2000 Feb; 35(2):398-404. PubMed ID: 10676687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure.
    Dickstein K; Manhenke C; Aarsland T; McNay J; Wiltse C; Wright T
    Int J Cardiol; 2000 Sep; 75(2-3):167-76; discussion 176-7. PubMed ID: 11077130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex.
    Szabo B; Fritz T; Wedzony K
    Br J Pharmacol; 2001 Sep; 134(2):295-304. PubMed ID: 11564647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).
    Cohn JN; Pfeffer MA; Rouleau J; Sharpe N; Swedberg K; Straub M; Wiltse C; Wright TJ;
    Eur J Heart Fail; 2003 Oct; 5(5):659-67. PubMed ID: 14607206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability and circulating catecholamine concentrations during steady state exercise in healthy volunteers.
    Breuer HW; Skyschally A; Schulz R; Martin C; Wehr M; Heusch G
    Br Heart J; 1993 Aug; 70(2):144-9. PubMed ID: 8038025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathoinhibitory mechanism of moxonidine: role of the inducible nitric oxide synthase in the rostral ventrolateral medulla.
    Peng J; Wang YK; Wang LG; Yuan WJ; Su DF; Ni X; Deng XM; Wang WZ
    Cardiovasc Res; 2009 Nov; 84(2):283-91. PubMed ID: 19535378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus.
    Furlan R; Porta A; Costa F; Tank J; Baker L; Schiavi R; Robertson D; Malliani A; Mosqueda-Garcia R
    Circulation; 2000 Feb; 101(8):886-92. PubMed ID: 10694528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart rate response to exercise and circulating catecholamines in heart transplant recipients.
    Ferretti G; Marconi C; Achilli G; Caspani E; Fiocchi R; Mamprin F; Gamba A; Ferrazzi P; Cerretelli P
    Pflugers Arch; 2002 Jan; 443(3):370-6. PubMed ID: 11810205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of sympathetic activity by eprosartan in young male subjects.
    Heusser K; Vitkovsky J; Raasch W; Schmieder RE; Schobel HP
    Am J Hypertens; 2003 Aug; 16(8):658-64. PubMed ID: 12878372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.